Treatment with low-dose warfarin reduced AXL-mediated human pancreatic cancer cells migration, invasiveness, and proliferation, while increasing apoptosis and sensitivity to chemotherapy. The gene discussed is AXL; the disease is familial pancreatic carcinoma.